Flag Therapeutics
Raleigh, US · North Carolina corporation
FLAG Therapeutics develops drug delivery and dosage form solutions for pharmaceutical development and manufacturing, serving biotech and pharmaceutical companies in oncology and rare disease therapeutics.
Founders & leadership
RA
RUHI AHMEDExecutive
FL
Frank L. SorgiPresident and Chief Executive Officer
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 2 rounds · 2016–2019
▶$72.5KraisedJul 2019 · 2 investors · PharmaceuticalsRule 506(b)
▶$72.5KraisedJul 2019 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- FRANK L. SORGIExecutive Officer, Director
- RUHI AHMEDExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $72.5K
- First sale
- Jun 2019
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$1.3MraisedJan 2019 · 14 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedJan 2019 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- FRANK L. SORGIExecutive Officer, Director
- RUHI AHMEDExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Mar 2016
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapFate Therapeutics3 shared keywordsFate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer. The company is conducting clinical trials on product candidates under strict regulatory and ethical standards.
Epicrispr Biotechnologies3 shared keywordsEpic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines. The company serves the biotech/medtech sector with advanced tools for precise gene expression control and disease treatment.
Companies competing with Flag Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Flag Therapeutics do?
- FLAG Therapeutics develops drug delivery and dosage form solutions for pharmaceutical development and manufacturing, serving biotech and pharmaceutical companies in oncology and rare disease therapeutics.
- How much funding has Flag Therapeutics raised?
- Flag Therapeutics has disclosed $1.4M raised across 2 rounds.
- Where is Flag Therapeutics headquartered?
- Flag Therapeutics is headquartered in Raleigh, US.